Work

Abstract B137: Pharmacokinetics and pharmacodynamic biomarkers for the dual PI3K/mTOR inhibitor GDC-0980: Initial phase I evaluation

Year: 2009

Type: conference-abstract

Source: Molecular Cancer Therapeutics

DOI: 10.1158/1535-7163.targ-09-b137

Authors: Andrew J. Wagner, Howard A. Burris, Johann S. de Bono, Gordon C. Jayson, Johanna C. Bendell, Carlos Gomez-Roca, Saoirse Dolly, Ying-Kiat Zee, Joseph A. Ware, Yibing Yan, Kathryn Mazina, Mika Derynck, Scott Holden, Jean-Charles Soria

Institutions: Dana-Farber Cancer Institute, Sarah Cannon, Institute of Cancer Research, The Christie Hospital, The Christie NHS Foundation Trust, Institut Gustave Roussy, Genentech

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2080518672

Cites:

Cited by: 8

Related to: 10